
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade Glioma.
Journal: Research square
Published: July 03, 2026
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.
Journal: Science advances
Published: February 27, 2026
Single-cell protein activity analysis reveals aberrant myogenesis and IGF2-PI3K pathway dependencies in MYOD1-mutant rhabdomyosarcoma.
Journal: Science advances
Published: February 27, 2026
CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.
Journal: Neuro-oncology
Published: February 13, 2026
An international framework for clinical translation of molecular classifiers in osteosarcoma.
Journal: NPJ precision oncology
Published: January 06, 2026
Blood-brain barrier opening with neuronavigation-guided focused ultrasound in pediatric patients with diffuse midline glioma.
Journal: Science translational medicine
Published: November 12, 2025
Targeted delivery of napabucasin with radiotherapy improves outcomes in diffuse midline glioma.
Journal: Neuro-oncology
Published: October 12, 2024
Elucidation and Pharmacologic Targeting of Master Regulator Dependencies in Coexisting Diffuse Midline Glioma Subpopulations.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2024
Focused ultrasound-mediated blood-brain barrier opening is safe and feasible with moderately hypofractionated radiotherapy for brainstem diffuse midline glioma.
Journal: Journal of translational medicine
Published: March 22, 2023
Immune Response following FLASH and Conventional Radiation in Diffuse Midline Glioma.
Journal: International journal of radiation oncology, biology, physics
Published: October 31, 2022
Last Updated: 09/26/2026